Compounds > rufloxacin
Page last updated: 2024-08-24

rufloxacin and Cirrhosis, Liver

rufloxacin has been researched along with Cirrhosis, Liver in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Granai, F; Imbimbo, BP; Triger, DR; Wise, R; Woodcock, J1
Bauer, TM; Bory, F; Clemente, G; Follo, A; Navasa, M; Planas, R; Rodés, J; Vaquer, P; Vargas, V; Vila, J1

Trials

1 trial(s) available for rufloxacin and Cirrhosis, Liver

ArticleYear
Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence.
    Digestive diseases and sciences, 2002, Volume: 47, Issue:6

    Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Humans; Liver Cirrhosis; Male; Middle Aged; Norfloxacin; Peritonitis; Prospective Studies; Quinolones; Secondary Prevention; Treatment Outcome

2002

Other Studies

1 other study(ies) available for rufloxacin and Cirrhosis, Liver

ArticleYear
Multiple-dose pharmacokinetics of rufloxacin in patients with cirrhosis.
    Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:4

    Topics: Adult; Aged; Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Administration Schedule; Female; Fluoroquinolones; Half-Life; Humans; Kidney; Liver; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Quinolones

1993